You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

Citation Tools

Article menu

Download PDFPDF

Short Oral Presentation
Short oral presentation session 16: SLE treatment 2
LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Navarra SV, Cornelisse P, Cahuzac C, et al
LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials
Lupus Science & Medicine 2023;10:doi: 10.1136/lupus-2023-KCR.133